Dementia

The FDA has approved a new version of an Alzheimer’s disease drug that can be given as a quick at-home weekly injection, offering patients a more convenient option than lengthy infusion-center visits. It will be widely available from October 6, 2025.

In a recent study researchers at UC San Francisco sought to identify the molecular troublemakers that cause our brains to age prematurely. Their goal? Find the sneaky agents behind age-related memory decline, and figure out how to stop them.

A loss of smell can be one of the earliest warning signs of Alzheimer’s disease, but the cause of this sensory change have been unclear. Now, a study reveals that the problem may not lie in the nose or olfactory bulb itself, as previously thought.

Just a few days after scientists announced we're at a pivotal tipping point in Alzheimer's disease research, a team has made a huge breakthrough, proving that mitochondrial dysfunction fuels memory loss. Then they engineered a way to restore it.

The fitness community regularly touts the health benefits of getting in 10,000 steps per day. But a new study says that a good deal fewer steps can still deliver significant benefits, including a 47% reduction in dying prematurely.

An extremely popular nerve pain drug commonly given to those suffering from low-back issues has been linked to impaired mental health including dementia and mild cognitive impairment. The risk was present after six or more prescriptions were filled.

If you could get a quick, easy scan in your 40s, which could add decades to your life and aging healthily, would you? Scientists have made such a tool, letting you glimpse into a crystal ball that identifies age-related disease risk long before onset.

A new study has found that your belly might reveal more about your brain health than your bathroom scales do, especially if you’re an older man. When it comes to dementia risk, the location of body fat, not just the amount, appears to be a factor.

A safe and affordable treatment to effectively combat the progress of Parkinson's dementia has emerged – in the form of a commonly available cough syrup that's already being studied for its brain-protecting power in other degenerative diseases.

Remarkable new findings about the sugar stores in neurons have unlocked an entire new method of treating cognitive decline, and it furthers our understanding of why GLP-1 weight loss drugs appear to provide a shield against Alzheimer's disease.

A readily available sleep aid has been shown to have a surprising side effect on brain health, seemingly protecting the organ from the buildup of the tau protein – a key biomarker in the development of neurodegenerative diseases including Alzheimer's.

Men who carry two copies of a common genetic variant are twice as likely to develop dementia than women with the same mutations. This discovery may now lead to early detection and novel interventions to block how these variants impact the brain.